Magellan Update October 2023

GMP LAB CONSTRUCTION COMPLETED Magellan has completed the construction of the GMP laboratory facility, with the emphasis now on balancing and testing systems. The installation of the Environmental Monitoring System (EMS) is largely complete. The research and development lab is being used to evaluate Bioreactor manufacturing methods and donor cells culturing, with a range of tests […]

Magellan Update July 2023

MAGELLAN APPOINTS NEW SHARE REGISTRY Magellan is pleased to announce that we have appointed Bio101 – a leading provider of financial, accounting, and company secretarial services to the biotechnology and life sciences sector – to provide our new secure share registry office service. The registry will hold details of members’ shareholdings as well as a library […]

Investment Enquiry

Download the full Investor Presentation